Pharma & Healthcare
Global Tenofovir Alafenamide Fumarate Tablets Market Research Report 2025
- Jun 01, 25
- ID: 284429
- Pages: 91
- Figures: 91
- Views: 25
The global market for Tenofovir Alafenamide Fumarate Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Tenofovir Alafenamide Fumarate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tenofovir Alafenamide Fumarate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tenofovir Alafenamide Fumarate Tablets include CSPC OUYI Pharmaceutical Co., Ltd., Gilead Sciences, Inc., Yichang Humanwell Pharmaceutical Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Reyoung Pharmaceutical Co., Ltd., Suzhou Homesun Pharmaceutical Co.,Ltd., Hunan Mingrui Pharmaceutical Co., Ltd., DESANO, Patheon Inc., Suzhou Thery Pharmaceutical Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tenofovir Alafenamide Fumarate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Alafenamide Fumarate Tablets.
The Tenofovir Alafenamide Fumarate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tenofovir Alafenamide Fumarate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenofovir Alafenamide Fumarate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSPC OUYI Pharmaceutical Co., Ltd.
Gilead Sciences, Inc.
Yichang Humanwell Pharmaceutical Co., Ltd.
Shandong Loncom Pharmaceutical Co., Ltd
Reyoung Pharmaceutical Co., Ltd.
Suzhou Homesun Pharmaceutical Co.,Ltd.
Hunan Mingrui Pharmaceutical Co., Ltd.
DESANO
Patheon Inc.
Suzhou Thery Pharmaceutical Inc.
Chengdu Easton Biopharmaceuticals Co.,Ltd.
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tenofovir Alafenamide Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tenofovir Alafenamide Fumarate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Tenofovir Alafenamide Fumarate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tenofovir Alafenamide Fumarate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tenofovir Alafenamide Fumarate Tablets include CSPC OUYI Pharmaceutical Co., Ltd., Gilead Sciences, Inc., Yichang Humanwell Pharmaceutical Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Reyoung Pharmaceutical Co., Ltd., Suzhou Homesun Pharmaceutical Co.,Ltd., Hunan Mingrui Pharmaceutical Co., Ltd., DESANO, Patheon Inc., Suzhou Thery Pharmaceutical Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tenofovir Alafenamide Fumarate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Alafenamide Fumarate Tablets.
The Tenofovir Alafenamide Fumarate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tenofovir Alafenamide Fumarate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenofovir Alafenamide Fumarate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSPC OUYI Pharmaceutical Co., Ltd.
Gilead Sciences, Inc.
Yichang Humanwell Pharmaceutical Co., Ltd.
Shandong Loncom Pharmaceutical Co., Ltd
Reyoung Pharmaceutical Co., Ltd.
Suzhou Homesun Pharmaceutical Co.,Ltd.
Hunan Mingrui Pharmaceutical Co., Ltd.
DESANO
Patheon Inc.
Suzhou Thery Pharmaceutical Inc.
Chengdu Easton Biopharmaceuticals Co.,Ltd.
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tenofovir Alafenamide Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tenofovir Alafenamide Fumarate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Tenofovir Alafenamide Fumarate Tablets Market Overview
1.1 Product Definition
1.2 Tenofovir Alafenamide Fumarate Tablets by Type
1.2.1 Global Tenofovir Alafenamide Fumarate Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Tenofovir Alafenamide Fumarate Tablets by Application
1.3.1 Global Tenofovir Alafenamide Fumarate Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tenofovir Alafenamide Fumarate Tablets Market Size Estimates and Forecasts
1.4.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue 2020-2031
1.4.2 Global Tenofovir Alafenamide Fumarate Tablets Sales 2020-2031
1.4.3 Global Tenofovir Alafenamide Fumarate Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tenofovir Alafenamide Fumarate Tablets Market Competition by Manufacturers
2.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tenofovir Alafenamide Fumarate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Product Type & Application
2.7 Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Date of Enter into This Industry
2.8 Global Tenofovir Alafenamide Fumarate Tablets Market Competitive Situation and Trends
2.8.1 Global Tenofovir Alafenamide Fumarate Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tenofovir Alafenamide Fumarate Tablets Players Market Share by Revenue
2.8.3 Global Tenofovir Alafenamide Fumarate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tenofovir Alafenamide Fumarate Tablets Market Scenario by Region
3.1 Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Region: 2020-2031
3.2.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Region: 2020-2025
3.2.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Region: 2026-2031
3.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2020-2031
3.3.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2020-2025
3.3.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2026-2031
3.4 North America Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.4.1 North America Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.4.3 North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.5.1 Europe Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.5.3 Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.7.1 Latin America Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.7.3 Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Type (2020-2031)
4.1.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Type (2020-2025)
4.1.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Type (2026-2031)
4.1.3 Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Type (2020-2031)
4.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Type (2020-2031)
4.2.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Type (2020-2025)
4.2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Type (2026-2031)
4.2.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Tenofovir Alafenamide Fumarate Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Application (2020-2031)
5.1.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Application (2020-2025)
5.1.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Application (2026-2031)
5.1.3 Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Application (2020-2031)
5.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Application (2020-2031)
5.2.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Application (2020-2025)
5.2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Application (2026-2031)
5.2.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Tenofovir Alafenamide Fumarate Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSPC OUYI Pharmaceutical Co., Ltd.
6.1.1 CSPC OUYI Pharmaceutical Co., Ltd. Company Information
6.1.2 CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.1.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Gilead Sciences, Inc.
6.2.1 Gilead Sciences, Inc. Company Information
6.2.2 Gilead Sciences, Inc. Description and Business Overview
6.2.3 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.2.5 Gilead Sciences, Inc. Recent Developments/Updates
6.3 Yichang Humanwell Pharmaceutical Co., Ltd.
6.3.1 Yichang Humanwell Pharmaceutical Co., Ltd. Company Information
6.3.2 Yichang Humanwell Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.3.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Shandong Loncom Pharmaceutical Co., Ltd
6.4.1 Shandong Loncom Pharmaceutical Co., Ltd Company Information
6.4.2 Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
6.4.3 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.4.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
6.5 Reyoung Pharmaceutical Co., Ltd.
6.5.1 Reyoung Pharmaceutical Co., Ltd. Company Information
6.5.2 Reyoung Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.5.5 Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Suzhou Homesun Pharmaceutical Co.,Ltd.
6.6.1 Suzhou Homesun Pharmaceutical Co.,Ltd. Company Information
6.6.2 Suzhou Homesun Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.6.5 Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Hunan Mingrui Pharmaceutical Co., Ltd.
6.7.1 Hunan Mingrui Pharmaceutical Co., Ltd. Company Information
6.7.2 Hunan Mingrui Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.7.5 Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 DESANO
6.8.1 DESANO Company Information
6.8.2 DESANO Description and Business Overview
6.8.3 DESANO Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DESANO Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.8.5 DESANO Recent Developments/Updates
6.9 Patheon Inc.
6.9.1 Patheon Inc. Company Information
6.9.2 Patheon Inc. Description and Business Overview
6.9.3 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.9.5 Patheon Inc. Recent Developments/Updates
6.10 Suzhou Thery Pharmaceutical Inc.
6.10.1 Suzhou Thery Pharmaceutical Inc. Company Information
6.10.2 Suzhou Thery Pharmaceutical Inc. Description and Business Overview
6.10.3 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.10.5 Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
6.11 Chengdu Easton Biopharmaceuticals Co.,Ltd.
6.11.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Information
6.11.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Description and Business Overview
6.11.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.11.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tenofovir Alafenamide Fumarate Tablets Industry Chain Analysis
7.2 Tenofovir Alafenamide Fumarate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tenofovir Alafenamide Fumarate Tablets Production Mode & Process Analysis
7.4 Tenofovir Alafenamide Fumarate Tablets Sales and Marketing
7.4.1 Tenofovir Alafenamide Fumarate Tablets Sales Channels
7.4.2 Tenofovir Alafenamide Fumarate Tablets Distributors
7.5 Tenofovir Alafenamide Fumarate Tablets Customer Analysis
8 Tenofovir Alafenamide Fumarate Tablets Market Dynamics
8.1 Tenofovir Alafenamide Fumarate Tablets Industry Trends
8.2 Tenofovir Alafenamide Fumarate Tablets Market Drivers
8.3 Tenofovir Alafenamide Fumarate Tablets Market Challenges
8.4 Tenofovir Alafenamide Fumarate Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Tenofovir Alafenamide Fumarate Tablets by Type
1.2.1 Global Tenofovir Alafenamide Fumarate Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Tenofovir Alafenamide Fumarate Tablets by Application
1.3.1 Global Tenofovir Alafenamide Fumarate Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tenofovir Alafenamide Fumarate Tablets Market Size Estimates and Forecasts
1.4.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue 2020-2031
1.4.2 Global Tenofovir Alafenamide Fumarate Tablets Sales 2020-2031
1.4.3 Global Tenofovir Alafenamide Fumarate Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tenofovir Alafenamide Fumarate Tablets Market Competition by Manufacturers
2.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tenofovir Alafenamide Fumarate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Product Type & Application
2.7 Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Date of Enter into This Industry
2.8 Global Tenofovir Alafenamide Fumarate Tablets Market Competitive Situation and Trends
2.8.1 Global Tenofovir Alafenamide Fumarate Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tenofovir Alafenamide Fumarate Tablets Players Market Share by Revenue
2.8.3 Global Tenofovir Alafenamide Fumarate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tenofovir Alafenamide Fumarate Tablets Market Scenario by Region
3.1 Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Region: 2020-2031
3.2.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Region: 2020-2025
3.2.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Region: 2026-2031
3.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2020-2031
3.3.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2020-2025
3.3.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2026-2031
3.4 North America Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.4.1 North America Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.4.3 North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.5.1 Europe Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.5.3 Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.7.1 Latin America Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.7.3 Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Type (2020-2031)
4.1.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Type (2020-2025)
4.1.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Type (2026-2031)
4.1.3 Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Type (2020-2031)
4.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Type (2020-2031)
4.2.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Type (2020-2025)
4.2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Type (2026-2031)
4.2.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Tenofovir Alafenamide Fumarate Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Application (2020-2031)
5.1.1 Global Tenofovir Alafenamide Fumarate Tablets Sales by Application (2020-2025)
5.1.2 Global Tenofovir Alafenamide Fumarate Tablets Sales by Application (2026-2031)
5.1.3 Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Application (2020-2031)
5.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Application (2020-2031)
5.2.1 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Application (2020-2025)
5.2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Application (2026-2031)
5.2.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Tenofovir Alafenamide Fumarate Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSPC OUYI Pharmaceutical Co., Ltd.
6.1.1 CSPC OUYI Pharmaceutical Co., Ltd. Company Information
6.1.2 CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.1.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Gilead Sciences, Inc.
6.2.1 Gilead Sciences, Inc. Company Information
6.2.2 Gilead Sciences, Inc. Description and Business Overview
6.2.3 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.2.5 Gilead Sciences, Inc. Recent Developments/Updates
6.3 Yichang Humanwell Pharmaceutical Co., Ltd.
6.3.1 Yichang Humanwell Pharmaceutical Co., Ltd. Company Information
6.3.2 Yichang Humanwell Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.3.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Shandong Loncom Pharmaceutical Co., Ltd
6.4.1 Shandong Loncom Pharmaceutical Co., Ltd Company Information
6.4.2 Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
6.4.3 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.4.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
6.5 Reyoung Pharmaceutical Co., Ltd.
6.5.1 Reyoung Pharmaceutical Co., Ltd. Company Information
6.5.2 Reyoung Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.5.5 Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Suzhou Homesun Pharmaceutical Co.,Ltd.
6.6.1 Suzhou Homesun Pharmaceutical Co.,Ltd. Company Information
6.6.2 Suzhou Homesun Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.6.5 Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Hunan Mingrui Pharmaceutical Co., Ltd.
6.7.1 Hunan Mingrui Pharmaceutical Co., Ltd. Company Information
6.7.2 Hunan Mingrui Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.7.5 Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 DESANO
6.8.1 DESANO Company Information
6.8.2 DESANO Description and Business Overview
6.8.3 DESANO Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DESANO Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.8.5 DESANO Recent Developments/Updates
6.9 Patheon Inc.
6.9.1 Patheon Inc. Company Information
6.9.2 Patheon Inc. Description and Business Overview
6.9.3 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.9.5 Patheon Inc. Recent Developments/Updates
6.10 Suzhou Thery Pharmaceutical Inc.
6.10.1 Suzhou Thery Pharmaceutical Inc. Company Information
6.10.2 Suzhou Thery Pharmaceutical Inc. Description and Business Overview
6.10.3 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.10.5 Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
6.11 Chengdu Easton Biopharmaceuticals Co.,Ltd.
6.11.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Information
6.11.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Description and Business Overview
6.11.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product Portfolio
6.11.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tenofovir Alafenamide Fumarate Tablets Industry Chain Analysis
7.2 Tenofovir Alafenamide Fumarate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tenofovir Alafenamide Fumarate Tablets Production Mode & Process Analysis
7.4 Tenofovir Alafenamide Fumarate Tablets Sales and Marketing
7.4.1 Tenofovir Alafenamide Fumarate Tablets Sales Channels
7.4.2 Tenofovir Alafenamide Fumarate Tablets Distributors
7.5 Tenofovir Alafenamide Fumarate Tablets Customer Analysis
8 Tenofovir Alafenamide Fumarate Tablets Market Dynamics
8.1 Tenofovir Alafenamide Fumarate Tablets Industry Trends
8.2 Tenofovir Alafenamide Fumarate Tablets Market Drivers
8.3 Tenofovir Alafenamide Fumarate Tablets Market Challenges
8.4 Tenofovir Alafenamide Fumarate Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tenofovir Alafenamide Fumarate Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tenofovir Alafenamide Fumarate Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tenofovir Alafenamide Fumarate Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tenofovir Alafenamide Fumarate Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tenofovir Alafenamide Fumarate Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tenofovir Alafenamide Fumarate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tenofovir Alafenamide Fumarate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Alafenamide Fumarate Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tenofovir Alafenamide Fumarate Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Tenofovir Alafenamide Fumarate Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. CSPC OUYI Pharmaceutical Co., Ltd. Company Information
Table 71. CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 74. CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Gilead Sciences, Inc. Company Information
Table 76. Gilead Sciences, Inc. Description and Business Overview
Table 77. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product
Table 79. Gilead Sciences, Inc. Recent Developments/Updates
Table 80. Yichang Humanwell Pharmaceutical Co., Ltd. Company Information
Table 81. Yichang Humanwell Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 84. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Shandong Loncom Pharmaceutical Co., Ltd Company Information
Table 86. Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
Table 87. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product
Table 89. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
Table 90. Reyoung Pharmaceutical Co., Ltd. Company Information
Table 91. Reyoung Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 94. Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Suzhou Homesun Pharmaceutical Co.,Ltd. Company Information
Table 96. Suzhou Homesun Pharmaceutical Co.,Ltd. Description and Business Overview
Table 97. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 99. Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 100. Hunan Mingrui Pharmaceutical Co., Ltd. Company Information
Table 101. Hunan Mingrui Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 104. Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. DESANO Company Information
Table 106. DESANO Description and Business Overview
Table 107. DESANO Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. DESANO Tenofovir Alafenamide Fumarate Tablets Product
Table 109. DESANO Recent Developments/Updates
Table 110. Patheon Inc. Company Information
Table 111. Patheon Inc. Description and Business Overview
Table 112. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product
Table 114. Patheon Inc. Recent Developments/Updates
Table 115. Suzhou Thery Pharmaceutical Inc. Company Information
Table 116. Suzhou Thery Pharmaceutical Inc. Description and Business Overview
Table 117. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product
Table 119. Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
Table 120. Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Information
Table 121. Chengdu Easton Biopharmaceuticals Co.,Ltd. Description and Business Overview
Table 122. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 124. Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Tenofovir Alafenamide Fumarate Tablets Distributors List
Table 128. Tenofovir Alafenamide Fumarate Tablets Customers List
Table 129. Tenofovir Alafenamide Fumarate Tablets Market Trends
Table 130. Tenofovir Alafenamide Fumarate Tablets Market Drivers
Table 131. Tenofovir Alafenamide Fumarate Tablets Market Challenges
Table 132. Tenofovir Alafenamide Fumarate Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tenofovir Alafenamide Fumarate Tablets
Figure 2. Global Tenofovir Alafenamide Fumarate Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tenofovir Alafenamide Fumarate Tablets Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Tenofovir Alafenamide Fumarate Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Tenofovir Alafenamide Fumarate Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Tenofovir Alafenamide Fumarate Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Tenofovir Alafenamide Fumarate Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Tenofovir Alafenamide Fumarate Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Tenofovir Alafenamide Fumarate Tablets Report Years Considered
Figure 16. Tenofovir Alafenamide Fumarate Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Tenofovir Alafenamide Fumarate Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Tenofovir Alafenamide Fumarate Tablets Players: Market Share by Revenue in Tenofovir Alafenamide Fumarate Tablets in 2024
Figure 19. Tenofovir Alafenamide Fumarate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Tenofovir Alafenamide Fumarate Tablets by Type (2020-2031)
Figure 52. Global Revenue Market Share of Tenofovir Alafenamide Fumarate Tablets by Type (2020-2031)
Figure 53. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Tenofovir Alafenamide Fumarate Tablets by Application (2020-2031)
Figure 55. Global Revenue Market Share of Tenofovir Alafenamide Fumarate Tablets by Application (2020-2031)
Figure 56. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Application (2020-2031)
Figure 57. Tenofovir Alafenamide Fumarate Tablets Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Tenofovir Alafenamide Fumarate Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tenofovir Alafenamide Fumarate Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tenofovir Alafenamide Fumarate Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tenofovir Alafenamide Fumarate Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tenofovir Alafenamide Fumarate Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tenofovir Alafenamide Fumarate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tenofovir Alafenamide Fumarate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Alafenamide Fumarate Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tenofovir Alafenamide Fumarate Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Tenofovir Alafenamide Fumarate Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. CSPC OUYI Pharmaceutical Co., Ltd. Company Information
Table 71. CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 74. CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Gilead Sciences, Inc. Company Information
Table 76. Gilead Sciences, Inc. Description and Business Overview
Table 77. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product
Table 79. Gilead Sciences, Inc. Recent Developments/Updates
Table 80. Yichang Humanwell Pharmaceutical Co., Ltd. Company Information
Table 81. Yichang Humanwell Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 84. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Shandong Loncom Pharmaceutical Co., Ltd Company Information
Table 86. Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
Table 87. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product
Table 89. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
Table 90. Reyoung Pharmaceutical Co., Ltd. Company Information
Table 91. Reyoung Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 94. Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Suzhou Homesun Pharmaceutical Co.,Ltd. Company Information
Table 96. Suzhou Homesun Pharmaceutical Co.,Ltd. Description and Business Overview
Table 97. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 99. Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 100. Hunan Mingrui Pharmaceutical Co., Ltd. Company Information
Table 101. Hunan Mingrui Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 104. Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. DESANO Company Information
Table 106. DESANO Description and Business Overview
Table 107. DESANO Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. DESANO Tenofovir Alafenamide Fumarate Tablets Product
Table 109. DESANO Recent Developments/Updates
Table 110. Patheon Inc. Company Information
Table 111. Patheon Inc. Description and Business Overview
Table 112. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product
Table 114. Patheon Inc. Recent Developments/Updates
Table 115. Suzhou Thery Pharmaceutical Inc. Company Information
Table 116. Suzhou Thery Pharmaceutical Inc. Description and Business Overview
Table 117. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product
Table 119. Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
Table 120. Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Information
Table 121. Chengdu Easton Biopharmaceuticals Co.,Ltd. Description and Business Overview
Table 122. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product
Table 124. Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Tenofovir Alafenamide Fumarate Tablets Distributors List
Table 128. Tenofovir Alafenamide Fumarate Tablets Customers List
Table 129. Tenofovir Alafenamide Fumarate Tablets Market Trends
Table 130. Tenofovir Alafenamide Fumarate Tablets Market Drivers
Table 131. Tenofovir Alafenamide Fumarate Tablets Market Challenges
Table 132. Tenofovir Alafenamide Fumarate Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tenofovir Alafenamide Fumarate Tablets
Figure 2. Global Tenofovir Alafenamide Fumarate Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tenofovir Alafenamide Fumarate Tablets Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Tenofovir Alafenamide Fumarate Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Tenofovir Alafenamide Fumarate Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Tenofovir Alafenamide Fumarate Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Tenofovir Alafenamide Fumarate Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Tenofovir Alafenamide Fumarate Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Tenofovir Alafenamide Fumarate Tablets Report Years Considered
Figure 16. Tenofovir Alafenamide Fumarate Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Tenofovir Alafenamide Fumarate Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Tenofovir Alafenamide Fumarate Tablets Players: Market Share by Revenue in Tenofovir Alafenamide Fumarate Tablets in 2024
Figure 19. Tenofovir Alafenamide Fumarate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Tenofovir Alafenamide Fumarate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Tenofovir Alafenamide Fumarate Tablets by Type (2020-2031)
Figure 52. Global Revenue Market Share of Tenofovir Alafenamide Fumarate Tablets by Type (2020-2031)
Figure 53. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Tenofovir Alafenamide Fumarate Tablets by Application (2020-2031)
Figure 55. Global Revenue Market Share of Tenofovir Alafenamide Fumarate Tablets by Application (2020-2031)
Figure 56. Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit) by Application (2020-2031)
Figure 57. Tenofovir Alafenamide Fumarate Tablets Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232